Amrix and Nucynta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Amrix (cyclobenzaprine hydrochloride) and Nucynta (tapentadol hydrochloride). Common drug interactions include gait disturbance among females.

The phase IV clinical study analyzes what interactions people have when they take Amrix and Nucynta. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Amrix?

Amrix has active ingredients of cyclobenzaprine hydrochloride. It is often used in back pain. eHealthMe is studying from 1,130 Amrix users. Check the latest studies of Amrix.

What is Nucynta?

Nucynta has active ingredients of tapentadol hydrochloride. It is often used in pain. eHealthMe is studying from 31,818 Nucynta users. Check the latest studies of Nucynta.



On Jul, 16, 2026

29 people who take Amrix and Nucynta together, and have interactions are studied.

Amrix and Nucynta drug interactions.

What are the common drug interactions of Amrix and Nucynta, by gender? *:

female:

  1. Gait disturbance
  2. Neuralgia (pain in one or more nerves)
  3. Fungal infection
  4. Gastric ulcer (stomach ulcer)
  5. Raynaud's phenomenon (discoloration of the fingers, toes, and occasionally other areas)
  6. Adverse event
  7. Abdominal rigidity
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  9. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

male:

n/a

What are the common drug interactions of Amrix and Nucynta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Application site erythema (redness of the skin at application site)
  2. Application site rash
  3. Drug ineffective
  4. Fungal infection
  5. Raynaud's phenomenon (discoloration of the fingers, toes, and occasionally other areas)
  6. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  7. Adverse event
  8. Ill-defined disorder
  9. Abdominal pain upper
  10. Angioedema (rapid swelling of the dermis)

50-59:

  1. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  2. Abdominal rigidity
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  5. Chest pain
  6. Fibromyalgia (a long-term condition which causes pain all over the body)
  7. Gastrointestinal infection (infection of stomach and intestine)
  8. Nausea (feeling of having an urge to vomit)
  9. Oesophageal spasm (contraction of oesophagus)
  10. Rotator cuff repair

60+:

  1. Drug screen positive
  2. Ankle fracture
  3. Hyperhidrosis (abnormally increased sweating)
  4. Oral herpes (viral infection of mouth)
  5. Therapeutic response unexpected

What are the existing conditions these people have? *

  1. Breakthrough Pain: 8 people, 27.59%
  2. Sleep Disorder: 7 people, 24.14%
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 24.14%
  4. Osteoporosis (bones weak and more likely to break): 6 people, 20.69%
  5. Fibromyalgia (a long-term condition which causes pain all over the body): 6 people, 20.69%
  6. Insomnia (sleeplessness): 5 people, 17.24%
  7. High Blood Cholesterol: 5 people, 17.24%
  8. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 5 people, 17.24%
  9. Migraine (headache): 4 people, 13.79%
  10. Neuralgia (pain in one or more nerves): 3 people, 10.34%

* Approximation only. Some reports may have incomplete information.

Do you take Amrix and Nucynta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Amrix and Nucynta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Amrix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nucynta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amrix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nucynta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cyclobenzaprine hydrochloride and tapentadol hydrochloride (the active ingredients of Amrix and Nucynta, respectively), and Amrix and Nucynta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: